Prediction at the end of the year 2002 suggest that the number of people undergoing dialysis will increase to a number far greater than predicted in earlier years. The prevalence of end-stage renal disease (ESRD) continues to grow throughout the world. This growth is driven by an aging population, an increased incidence of diseases associated with kidney damage (especially diabetes), and greater access to dialysis therapy. The costs of treating ESRD patients also is growing and represents a difficult economic problem throughout the world and this could lead to economic factors that impose restrictions on treatment. In short, new methods of preventing and treating chronic kidney disease (CKD) are required.
It has been known for over 130 years that dietary protein restriction is a critical aspect of the management of CKD. A principle goal of a well-planned, (very) low protein dietary regime is to decrease the accumulation of unexcreted waste products while maintaining an adequate nutritional state and improving symptoms of uraemia. This goal has been achieved by compliant CKD patients. When the diet contains less than the minimum daily requirement of 0.6 g protein/kg b.w./day, it is necessary to supply a supplement of essential amino acids or their nitrogen-free analogues (keto acids) to meet nutritional needs of CKD patients. These diets are sufficient for maintaining or improving nutritional status.
The International Advisory Board Meetings focus on identifying the risks and treatment potential for protein-restricted diets for CKD patients, especially dietary regimens supplemented with keto/amino acids.
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